We demonstrate using Ca 2 þ -dependent calmodulin (CaM)-affinity chromatography and overlay with biotinylated CaM that the adaptor proteins growth factor receptor bound (Grb)7 and Grb7V (a naturally occurring variant lacking the Src homology 2 (SH2) domain) are CaM-binding proteins. Deletion of an amphiphilic basic amino-acid sequence (residues 243-256) predicted to form an a-helix located in the proximal region of its pleckstrin homology (PH) domain demonstrates the location of the CaM-binding domain. This site is identical in human and rodents Grb7, and shares great homology with similar regions of Grb10 and Grb14, and the Mig10 protein from Caenorhabditis elegans. We show that Grb7 and Grb7V are present in the cytosol and bound to membranes, while the deletion mutants (Grb7D and Grb7VD) have less capacity to be associated to membranes. Grb7D maintains in part the capacity to bind phosphoinositides, and CaM competes for phosphoinositide binding. Activation of ErbB2 by heregulin b1 decreases the pool of Grb7 associated to membranes. The cell-permeable CaM antagonist W7 (N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide), but not the CaM-dependent protein kinase II inhibitor KN93, prevents this effect. Highly specific cell-permeable CaM inhibitory peptides decrease the association of Grb7 to membranes. This suggests that CaM regulates the intracellular mobilization of Grb7 in living cells. Direct interaction between enhanced yellow fluorescent protein (EYFP)-Grb7 and enhanced cyan fluorescent protein (ECFP)-CaM chimeras at the plasma membrane of living cells was demonstrated by fluorescence resonance energy transfer (FRET). The FRET signal dramatically decreased in cells loaded with a cellpermeable Ca 2 þ chelator, and was significantly attenuated when enhanced yellow fluorescent protein-Grb7 chimera (EYFP-Grb7)D instead of EYFP-Grb7 was used. Finally, we show that conditioned media from cells transiently transfected with Grb7D and Grb7VD lost its angiogenic activity, in contrast to those from cells transiently transfected with their wild-type counterparts.
Introduction
We have previously demonstrated that calmodulin (CaM) binds to the cytosolic juxtamembrane region of the EGF receptor (EGFR) in a Ca 2 þ -dependent manner, acting as a negative regulator of its intrinsic tyrosine kinase activity (San Jose´et al., 1992; Martı´n-Nieto and Villalobo, 1998; Li and Villalobo, 2002; Li et al., 2004a) . We have also demonstrated that CaM specifically binds to ErbB2 in a Ca 2 þ -dependent manner (Li et al., 2004b) . To further understand the role of CaM on the physiology of ErbB receptors, we were interested in knowing if CaM binds as well to adaptor proteins associated to these receptors.
Growth factor receptor bound (Grb) proteins are adaptors that lack enzymatic activity and exert their functions binding to phosphotyrosine (P-Tyr) residues of activated tyrosine kinase receptors, and other tyrosine-phosphorylated proteins, by their Src homology 2 (SH2) domain. The Grb7 protein family is formed by three currently known members: Grb7, Grb10, and Grb14 (Daly, 1998; Han et al., 2001; Morrione, 2003; Villalobo et al., 2003; Cariou et al., 2004; Lim et al., 2004; Riedel, 2004; Shen and Guan, 2004) . These proteins are related to the Caenorhabditis elegans Mig10 protein, which is involved in the regulation of embryonic neural cell migration (Manser and Wood, 1990) . The Grb7 protein family plays important functions as downstream signaling molecules of tyrosine kinase receptors including the EGFR, ErbB2, ErbB3, and ErbB4 (Daly, 1998; Fiddes et al., 1998; Han et al., 2001 ). In particular, Grb7 controls cell migration, a process that appears to be mediated by its interaction with focal adhesion kinase (FAK), and the phosphorylation of the adaptor protein by this integrin-regulated kinase (Han and Guan, 1999; Han et al., 2001) ; and/or by its interaction with the EphB1 receptor, and subsequent tyrosine phosphorylation of the adaptor protein .
Grb7 is found coamplified with ErbB2 in breast, esophageal, and gastric adenocarcinoma cells (Stein et al., 1994; Kishi et al., 1997; Tanaka et al., 1998) . This coamplification nicely correlates with the enhanced invasive capacity of these tumor cells, suggesting that Grb7 plays a role in ErbB2-mediated cell motility and extramucosa tumor cell invasion (Tanaka et al., 1997) .
The number of proteins known to interact with Grb7, and other members of this protein family, has increased steadily over time (Han et al., 2001) . Nevertheless, the functional consequences of most of these interactions are not yet well understood. Hence, to comprehend the various physiological roles that Grb7 may play in living cells, it would require to search for additional protein binding partners, some of which may play regulatory functions relevant for the interaction of Grb7 with signaling molecules. In this report, we demonstrate that human Grb7 and Grb7V -a naturally occurring truncated variant lacking the SH2 domain implicated in extramucosa tumor cell invasion and metastatic spread (Tanaka et al., 1998) bind CaM in a specific Ca 2 þ -dependent manner in vitro and in vivo, and that CaM exerts a regulatory role on intracellular Grb7 mobilization. Overall, our results suggest that the signaling function of this adaptor protein could be under the control of the Ca 2 þ signal generated by their accomplices upstream tyrosine kinase receptors.
Results

Isolation of Grb7 by immobilized CaM
CaM-affinity chromatography is a convenient method for the isolation of CaM-binding proteins from complex biological samples (Klee and Vanaman, 1982) . We selected human adenocarcinoma SK-BR-3 cells to test the isolation of Grb7 by this technique since this cell line overexpresses both Grb7 and ErbB2, a known binding partner of Grb7 (Janes et al., 1997) . Figure 1a shows that Grb7 can be isolated from the SK-BR-3 cytosolic fraction (CF) by Ca 2 þ -dependent CaM-affinity chromatography upon EGTA ([ethylene bis(oxyethylenenitrilo)]-tetraacetic acid) elution (EGTA, fractions 1-3), while it is absent in the effluent before EGTA addition (Ca 2 þ ). A control using the whole tumor cell extract (CE) is shown. Similar results were obtained from a lysate of Escherichia coli expressing recombinant Grb7 (Figure 1b, top panel) . A negative control using only the secondary antibody is shown (Figure 1b , bottom panel).
Physical interaction between CaM and Grb7
The above-described results could also indicate that Grb7 may be associated to a distinct bona fide CaMbinding protein(s) traveling piggy-back during its isolation by CaM-affinity chromatography. To rule out this possibility, we overlaid different Grb7 preparations with biotinylated CaM. Figure 2a shows that when proteins from SK-BR-3 cells extract were overlaid with biotinylated CaM, a specific signal was detected in the presence but not in the absence of Ca 2 þ (presence of EGTA) (right panel). This band coincides in its central part with Grb7 as probed by immunoblot (left panel). We performed similar experiments using the protein fraction pulled down by CaM-agarose in the presence of Ca 2 þ (Figure 2b) . Thus, the CE and the purified protein (PP) fraction associated to the CaM-agarose beads gave a 59 kDa positive signal with biotinylated CaM (right panel), perfectly matching the position of Grb7 (left panel). Interestingly, the electrophoretic mobility of the purified Grb7 protein (PP) bound to CaM-agarose was slightly higher than the bulk of Grb7 detected in the CE. We performed control experiments with a nonrelevant immobilized protein (protein A) covalently bound to agarose to exclude unspecific binding (not shown). Moreover, Figure 2c (top panel) shows that recombinant Grb7 interacts with biotinylated CaM in the presence but not in the absence of Ca 2 þ (presence of EGTA). The addition of an excess A SK-BR-3 tumor cell CF (10 ml containing 15 mg protein) was subjected to Ca 2 þ -dependent CaM-affinity chromatography as described in Materials and methods. Fractions were collected using a buffer containing 0.2 mM CaCl 2 (Ca 2 þ ), and a buffer containing 2 mM EGTA (EGTA, lanes 1-3). A control using the CE (100 mg protein) is also presented. The trichloroacetic acid-precipitated samples were probed with an anti-Grb7 antibody. (b) A CE (7.7 mg protein) from E. coli expressing recombinant Grb7 was subjected to CaM-affinity chromatography and processed as indicated above (top panel). A control using the secondary (IgG) antibody only (bottom panel) is presented. The arrow points to the 59 kDa Grb7 band Grb7 binds calmodulin H Li et al of free CaM displaces the binding of its biotinylated form, demonstrating that this interaction was specific. A negative control using only streptavidin peroxidase is also presented. The loading of Grb7 was determined probing with an anti-Grb7 antibody (bottom panel). We calculated K 0 d 's of E30 nM and E1 mM, respectively, for CaM binding to tumor and recombinant Grb7 (not shown).
CaM-binding domain (CaM-BD) of Grb7
Two classes of motifs forming CaM-BDs have been described: (i) the IQ motifs, with the general consensus sequence [I,L,V,M]QXXXRXXXX [R,K] , where X represents any amino acid (Jurado et al., 1999; Ba¨hler and Rhoads, 2002) ; and (ii) short amphiphilic basic sequences, in which positive charged and hydrophobic residues are segregated into opposite sides of an a-helix (O'Neil and DeGrado, 1990 ). We have not found any IQ motif in the Grb7 sequence. In contrast, a canonical amphiphilic basic a-helix spanning residues 243-256, and bearing the sequence RKLWKRFFCFLRRS, overlaps the proximal region of the pleckstrin homology (PH) domain of human Grb7 and Grb7V, as it is highlighted in Figure 3a . A helical wheel plot representation of this segment clearly shows the basic residues on one side of the helix and most of the hydrophobic residues segregated into the opposite side (Figure 3b) .
To test whether the proposed CaM-BD of Grb7 and Grb7V has indeed the capacity to bind CaM, we prepared mutants deleting the sequence from R243 to S256. We denoted the mutated forms Grb7D and Grb7VD. Figure 4 shows that Grb7D and Grb7VD lost in great extent the capacity to hybridize with biotinylated CaM in the presence of Ca 2 þ as compared to their wild-type counterparts (top panel). The binding of biotinylated CaM in the presence of EGTA was nil as expected (central panel). Loading controls are also presented (bottom panel). Notice the slight different molecular masses of the two deletion mutants Grb7D (E57.5 kDa) and Grb7VD (E47.5 kDa), as compared, respectively, to Grb7 (59 kDa) and Grb7V (49 kDa). The densitometric reading of the biotinylated CaM signal corrected by the loading signal show that the average7s.d. CaM-binding capacity of Grb7D and Grb7VD was, respectively, 2275% (n ¼ 4) and 2674% (n ¼ 2) of their corresponding wild-type controls.
The identified CaM-BD of human Grb7 and Grb7V is identical in rat and mouse Grb7, and highly conserved homologous sequences are present in Grb14 and Grb10 Figure 3 The structure of the CaM-BD of Grb7 and Grb7V. (a) The sequence and location of the CaM-BD (residues R243-S256) is indicated in the general structure of human Grb7 and Grb7V. PR, proline-rich domain; RA, Ras-associating domain; PH, pleckstrin homology domain; BPS, between PH and SH2 domain; SH2, Src homology 2 domain. (b) The helical wheel plot representation of the CaM-BD shows that positive charged residues ( þ ), and hydrophobic residues (bold face) are segregated to opposite sides of the helix. The putative phosphorylatable serine residue is underlined Grb7 binds calmodulin H Li et al of the same species, maintaining from 78 to 85% homology. A similar sequence located in the Mig10 protein from C. elegans with 64% homology to human Grb7 was also noticeable (see Table 1 ).
Expression and intracellular localization of active recombinant Grb7 variants
To establish a possible regulatory role of CaM on the functionality of Grb7, we transiently transfected Flagtagged Grb7, Grb7D, Grb7V, and Grb7VD in HEK293T cells. Figure 5 shows that the four adaptor protein variants were highly expressed as detected using an anti-Flag antibody (top panel), and an anti-Grb7 antibody against its N-terminal (central panel). A control with nontransfected (NT) cells shows the absence of detectable endogenous Grb7 in this cell line. The adaptor proteins were phosphorylated at tyrosine residues in basal conditions (bottom panel) as detected in the total cell extract. We confirmed the phosphorylation status of Grb7 and Grb7D after immunoprecipitation, and demonstrated that this phosphorylation was not enhanced by heregulin b1 (HRGb1) (not shown). This suggests that these proteins were functionally active Figure 4 Identification of the CaM-BD of Grb7 and Grb7V. Cell extracts (from 10 ml cultures) from E. coli expressing IPTG-induced recombinant Grb7, Grb7D, Grb7V, or Grb7VD were subjected to overlay with 14.5 nM biotinylated CaM in the presence of 0.2 mM CaCl 2 (top panel), or 1 mM EGTA (central panel) as described in Materials and methods. The loading was determined in the stripped membrane using an anti-Grb7 antibody (bottom panel). The top arrow points to the 59 kDa Grb7 and E57.5 kDa Grb7D bands, and the bottom arrow points to the 49 kDa Grb7V and E47.5 kDa Grb7VD bands Amino-acid residues corresponding to the CaM-BD of human Grb7, and homologous sequences in other Grb7 family members are represented by the single-letter code. Identities are indicated by a dot and conservative substitutions by lower-case letters. The percent identity/conservation for the CaM-BD and whole protein sequences are indicated Figure 5 Transient expression, and tyrosine phosphorylation of Grb7, Grb7D, Grb7V, and Grb7VD in mammalian cells. Total cell extracts (60 mg protein) from HEK293T cells transiently transfected with Flag-tagged Grb7, Grb7D, Grb7V, or Grb7VD were probed with anti-Flag (top panel), anti-Grb7 (central panel), or anti-P-Tyr (bottom panel) antibodies as described in Materials and methods. Controls using NT cells are also presented. The top arrow points to the 59 kDa Grb7 and E57.5 kDa Grb7D bands, and the bottom arrow points to the 49 kDa Grb7V and E47.5 kDa Grb7VD bands (Han and Guan, 1999; Han et al., 2000) . Figure 6 shows that Grb7 (top left panel) is uniformly distributed in the cytosol of HEK293T cells as observed using an anti-Flag antibody coupled to a fluorescein isothiocyanate (FITC)-labeled secondary anti-IgG antibody (green), while Grb7D (top right panel) presents a less uniform distribution with conspicuous intracellular aggregates (see arrows). Similar uniform cytosolic distribution of Grb7V, and the presence of Grb7VD intracellular aggregates were detected (not shown).
Intracellular aggregates of Grb7D and Grb7VD were observed in E40-60% of cells positively transfected depending of the preparations. The variable appearance of these granular structures could be due to different levels of expression of Grb7D or Grb7VD. We did not observe any significant change in cell morphology, intracellular organelle distribution, cell clustering, cell growth rate, or actin cytoskeleton organization among the different transfectants (not shown).
The addition of HRGb1 for 1 h ( Figure 6 , middle left panel), or 30 min (not shown) induces the accumulation of wild-type Grb7 in intracellular aggregates with reticular and/or punctual appearance (see arrows). These aggregates were alike to those observed with Grb7D in basal conditions (top right panel). No significant further increase in the formation of aggregates was observed in cells expressing Grb7D upon HRGb1 treatment (not shown). Immunostaining of endosomes using an anti-EEA1 antibody coupled to an Alexa Fluor s 594-labeled secondary anti-IgG antibody (red) gave a very weak signal (middle right panel), and no colocalization with Grb7D associated to the intracellular aggregates was observed (see top right panel). Similarly, no colocalization was detected between EEA1 and HRGb1-induced wild-type Grb7 aggregates (not shown). A positive control with PAE/EGFR-green fluorescent protein chimera (EGFR-GFP) cells in which the chimera EGFR-GFP (green) colocalizes with EEA1 (red) upon EGF addition for 30 min is presented (bottom panels).
We performed subcellular fractionation of transiently transfected HEK293T cells and determined that the mean7s.e.m. binding of Grb7D and Grb7VD to the Triton X-100-soluble membrane (SM) fraction was, respectively, 1074% (n ¼ 4) and 1478% (n ¼ 3) of their wild-type forms (not shown).
As the CaM-BD of Grb7 is located within its PH domain, the absence of the CaM-BD in Grb7D could be responsible for its failure to bind to phosphoinositides, and thereby to the Triton X-100-SM fraction, since it has been shown that a single site mutation in the PH domain of Grb7 affects its binding capacity to membrane-associated phosphoinositides . Figure 7b demonstrates that, in the presence of EGTA, wild-type Grb7 binds to immobilized phosphoinositides (center subpanel), and that Grb7D has lower phosphoinositide binding capacity, although it significantly retains the ability to associate to phosphatidyl-3-phosphate, and phosphatidyl-3,5-bisphosphate (right subpanel). In the presence of Ca 2 þ (Figure 7c ), however, the association of wild-type Grb7 to phosphoinositides greatly diminishes (center subpanel), as it would be expected because competition with endogenous CaM is present in the CF of HEK293T cells. Moreover, the addition of exogenous CaM further decreases the capacity of Grb7 to bind phosphoinositides (right subpanel). Controls using the CF of NT cells (control in Figure 7b and c), a drawing of the different immobilized phospholipids tested (Figure 7a ), and the expression levels of Grb7 and Grb7D (Figure 7d ), are presented. shows a false-color image where significant FRET efficiency (red color) between enhanced cyan fluorescent protein-calmodulin chimera (ECFP-CaM) and enhanced yellow fluorescent protein-Grb7 chimera (EYFP-Grb7) was detected at the cell plasma membrane. The bottom panels of Figure 8a show the emission fluorescence of both the donor (D) ECFPCaM and acceptor (A) EYFP-Grb7 before (pre) and after (post) acceptor photobleaching in the selected region, where increased emission fluorescence of ECFPCaM was detected. Depending of the total area analysed, we found in different experiments a FRET efficiency ranging approximately from 4 to 16%.
To determine the Ca 2 þ dependency of the detected interaction, we performed similar experiments with cells loaded with the cell-permeable Ca 2 þ chelator BAPTA-AM ([1,2-bis(o-aminophenoxy)ethane-N,N,N 0 ,N 0 -tetraacetic acid tetra(acetoxymethyl) ester]). Figure 8b shows a dramatic decrease in FRET efficiency in BAPTA-AMloaded cells cotransfected with ECFP-CaM and EYFPGrb7 (center panel) as compared with control untreated cells (top panel). We also observed a significant but not total decrease in FRET efficiency in cells cotransfected with ECFP-CaM and EYFP-Grb7D instead of EYFPGrb7 (bottom panel). The correct expression of the 84 kDa EYFP-Grb7, the E82.5 kDa EYFP-Grb7D and the E46 kDa ECFP-CaM was ascertained by immunoblot using anti-Grb7 and anti-CaM antibodies (not shown).
Regulatory role of CaM on Grb7 mobilization and its association to cell membranes
We tested in SK-BR-3 cells whether Grb7 mobilization could be induced by ErbB2 activation, and if this process is regulated by CaM. Figure 9a displays the absence or presence of ErbB2 (top panel) and Grb7 (bottom panel) in the cytosolic fraction (CF), a Triton X-100-soluble membrane (SM) fraction, and a Triton X-100-insoluble particulate (IP) fraction in nonstimulated and HRGb1-stimulated cells. As expected, ErbB2 was absent from the CF, while it was present in the Triton X-100-SM fraction (top panel). Surprisingly, ErbB2 was also present in the Triton X-100-IP fraction. Grb7, however, was in great extent located in the CF and the Triton X-100-IP fraction, and in a lesser extent in the Triton X-100-SM fraction. HRGb1 treatment decreases Grb7 in the Triton X-100-SM fraction, suggesting that activation of ErbB2 by HRGb1 induces Grb7 mobilization.
To determine the role of CaM on the observed ErbB2 activation-mediated Grb7 mobilization, we performed similar experiments in nontreated and cells treated using the cell-permeable CaM antagonist naphthalenesulfonamide derivative W7 (N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide) (Nishikawa et al., 1980) . Figure 9b shows the HRGb1-induced decrease of Grb7 the Triton X-100-SM fraction of cells not treated with W7 (bottom panel). In contrast, this effect was prevented in cells treated with W7 (bottom panel). The total (central panel) and phosphorylated form (top panel) of ErbB2 are also shown. Densitometric readings show that HRGb1 increases the mean7s.e.m. tyrosine phosphorylation status (345786%, n ¼ 4) of ErbB2, while W7 induces a slight but significant decrease in this phosphorylation (2677%, n ¼ 4) in agreement with our previous data (Li et al., 2004b) . Figure 9c shows that HRGb1 in the absence of W7 decreases the mean7 s.e.m. amount of Grb7 in the Triton X-100-SM fraction to 6878% (n ¼ 9), while this value reaches 79718% (n ¼ 4) with W7 alone, and the further addition of HRGb1 somewhat increases this value to 88717 (n ¼ 4). Binding of Grb7 and Grb7D to phosphoinositides, and competitive effect of CaM. (a) Immobilized phospholipids in the PIP Stripst membranes used to test the binding capacity of Grb7 and Grb7D as described in Materials and methods were as follows: lysophosphatidic acid, LPA; lysophosphatidylcholine, LPC; phosphatidylinositol, PI; phosphatidylinositol-3-phosphate, PI(3)P; phosphatidylinositol-4-phosphate, PI(4)P; phosphatidylinositol-5-phosphate, PI(5)P; phosphatidylethanolamine, PE; phosphatidylcholine, PC; sphingosine-1-phosphate, S1P; phosphatidylinositol-3,4-bisphosphate, PI(3,4)P 2 ; phosphatidylinositol-3,5-bisphosphate, PI(3,5)P 2 ; phosphatidylinositol-4,5-bisphosphate, PI(4,5)P 2 ; phosphatidylinositol-3,4,5-trisphosphate, PI(3,4,5)P 3 ; phosphatidic acid, PA; phosphatidylserine, PS; and a blank. The arrow points to the 59 kDa Grb7 and E57.5 kDa Grb7D bands
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In contrast, the addition of KN93, a CaM-dependent protein kinase II (CaMK-II) inhibitor, decreases the mean7s.e.m. amount of Grb7 bound to the Triton X-100-SMs to 6479 (n ¼ 5) in the absence of HRGb1, and to 56710 (n ¼ 5) in its presence. KN93 also increases the phosphorylation of ErbB2 (not shown), suggesting that CaMK-II downregulates this receptor as reported (Feinmesser et al., 1996) .
As noticed in Figure 9c , W7 alone induces a small decrease in the amount of Grb7 associated to the Triton X-100-SM fraction. This suggests that CaM could have a regulatory role. In order to confirm it, we performed additional experiments in Grb7-transfected HEK293T cells using, instead of W7 cell-permeable, highly specific, high-affinity (K 0 d ¼ 6 pM) CaM inhibitory peptides based on the CaM-BD of myosin light-chain kinase (To¨ro¨k and Trentham, 1994; To¨ro¨k et al., 1998a, b; Thorogate and To¨ro¨k, 2004) . Figure 10a (top left panel) shows that incubation of Grb7-transfected HEK293T cells with a myristoylated version of the CaM inhibitory peptide (mMLCK-P) nearly totally prevents the association of Grb7 to the Triton X-100-SM fraction. In contrast, a myristoylated control peptide (mCtrl-P) with a six order of magnitude lower affinity for CaM (K 0 d ¼ 4.7 mM) (To¨ro¨k et al., 1998b) has a far lesser effect. A control using cells transfected with the mutant Grb7D (top right panel), and protein loading controls (bottom panels) are shown. To ascertain that the observed effect was not due to disruption of the membrane organization, we used the acylated versions of the CaM inhibitory peptide (aMLCK-P) and the control peptide (aCtrl-P) at lower concentrations than in previous experiments because these acylated peptides are less likely to stick to the membranes. Figure 10b (top right panel) shows that aMLCK-P strongly prevents the association of Grb7 to the membrane fraction (MF), while aCtrl-P has only a minor effect. Treatment of the cells with these peptides does not remove tightly bound CaM from the membranes (center right panel). Figure 10b also shows the Abolition of angiogenic activity of conditioned media from HEK293T cells transiently transfected with Grb7D and Grb7VD
We tested the angiogenic activity of conditioned media from HEK293T cells transiently transfected with Grb7, Grb7V, Grb7D, and Grb7VD using human brain endothelial (HBE) cells. As shown in Figure 11 , HBE cells displayed flat polygonal morphology and no capillary-like tubes formation was observed in serumfree medium (panel a 
Discussion
Activation of tyrosine kinase receptors, including the EGFR and ErbB2, generates a transient rise in the cytosolic concentration of free Ca 2 þ , which is relevant for the negative feedback control of their tyrosine kinase activity (Villalobo et al., 2000) . The demonstration that Grb7 interacts with CaM in a Ca 2 þ -dependent manner suggests that the Ca 2 þ signal evoked by upstream tyrosine kinase receptors may play a role regulating Grb7. As most of the regulatory mechanisms and signaling pathways mediating the action of Grb7 are yet unknown, this observation could shed some light on this process.
Our results clearly show that human Grb7, and its truncated variant Grb7V (Tanaka et al., 1998) , specifically bind CaM in a Ca 2 þ -dependent manner. Furthermore, we have determined that residues 243-256 form the CaM-BD. Nevertheless, the residual (22-26%) CaM-binding capacity detectable in Grb7D and Grb7VD suggests that additional amino-acid residues, not comprised in the R243-S256 segment, may contribute to Ca 2 þ -dependent CaM binding. The affinity of CaM for recombinant Grb7 (K 0 d E1 mM) appears to be lower than for Grb7 from SK-BR-3 tumor cells (K 0 d E30 nM) pulled down by CaM-agarose beads. The reason for this discrepancy is not clear, as we cannot exclude that a high affinity Figure 9 CaM-regulated heregulin b1-mediated intracellular mobilization of Grb7. (a) SK-BR-3 cells were incubated in the absence and presence of 100 ng/ml HRGb1 for 2 min as indicated. The cells were subjected to subcellular fractionation, and aliquots of the cytosolic fraction (CF) (150 mg protein), the complete Triton X-100-SM fraction, and the complete Triton X-100-IP fraction were probed for ErbB2 (top panel) and Grb7 (bottom panel) as described in Materials and methods. Arrows point either to the 185 kDa ErbB2 (top panel) or the 59 kDa Grb7 (bottom panel) bands. (b) SK-BR-3 cells were incubated in the absence and presence of 5 mg/ml W7 for 30 min, and thereafter with 100 ng/ml HRGb1 for 2 min as indicated. The Triton X-100-SM fraction was first probed with an anti-P-Tyr antibody (top panel), and striped and reprobed with an anti-ErbB2 antibody (central panel), and the lower part of the nitrocellulose membrane was probed with an antiGrb7 antibody (bottom panel) as described in Materials and methods. Arrows point either to the phosphorylated (top panel) and total (central panel) 185 kDa ErbB2, and the 59 kDa Grb7 (bottom panel) bands. (c) SK-BR-3 cells were incubated in the absence or presence of 5 mg/ml W7 for 30 min, or 2 mM KN93 for 1 h, and thereafter with 100 ng/ml HRGb1 for 2 min as indicated. The Triton X-100-SM fraction was probed with anti-ErbB2 and anti-Grb7 antibodies as described in Materials and methods. The plot represents the densitometry of the anti-Grb7/anti-ErbB2 signals ratio. The 100% value was considered the signal ratio in non-treated cells (None). The mean7s.e.m. obtained in 9 (None and HRGb1), 4 (W7 and W7 þ HRGb1), and 5 (KN93 and KN93 þ HRGb1) independent experiments are shown. Statistically significant differences were found between the None and HRGb1 groups (P ¼ 0.001), and the HRGb1 and HRGb1 þ W7 groups (P ¼ 0.05)
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unrelated CaM-binding protein of identical molecular mass than Grb7 is present in the tumor cells preparation. Nevertheless, the possibility that post-translational modification(s) (absent in recombinant Grb7) could increase the affinity of CaM for the tumor Grb7 should be taken in consideration.
The different electrophoretic mobility of the bulk Grb7 present in the CE compared to the form that binds to CaM-agarose suggests that two distinct populations of Grb7 could be present in SK-BR-3 tumor cells. Two possibilities could explain this observation: (i) The presence of tightly bound small molecules not removable by sodium dodecyl sulfate (hydrophobic interactions) and/or (ii) post-translational modification(s).
The identification of highly homologous sequence motifs able to work as potential CaM-BDs in other members of the Grb7 adaptor protein family such as distinct mammalian Grb10 and Grb14 proteins, and even in the Mig10 protein from C. elegans, strongly suggests that they could also be CaM-binding proteins. If this is so, the functional role of CaM on these adaptor proteins could have an ancestral origin, controlling the multiple functions of these adaptor proteins.
The CaM-BD of proteins usually contains phosphorylatable amino acids that prevent the binding of CaM after phosphorylation. Conversely, the binding of CaM prevents the phosphorylation event. We have demonstrated this interplay in the CaM-BD of the human EGFR (Martı´n-Nieto and Villalobo, 1998) . Interestingly, a conserved serine residue is present in the distal part of the proposed CaM-BDs of all members of the Grb7 protein family including the Mig10 protein from C. elegans. Moreover, the presence of additional conserved serine and tyrosine residues in the putative CaM-BDs of all the Grb7 family members, except in Grb7 itself, are also conspicuous features of these domains. Further work should determine whether the phosphorylation of any of these residues could have any effect on the CaM-binding capacity of these proteins.
CaM is a versatile Ca 2 þ sensor that regulates multiple cellular systems (Chin and Means, 2000) . This regulation is usually carried out by three mechanisms: (i) releasing an autoinhibitory domain from the catalytic site of an enzyme, (ii) rearranging its catalytic site, or (iii) inducing protein dimerization (Hoeflich and Ikura, 2002) . As Grb7 does not have an intrinsic enzymatic activity nor a transport function, it would be interesting to see the actual mode of action of CaM on this and other adaptor proteins. Figure 10 CaM regulates the association of Grb7 to cell membranes. (a) HEK293T cells transfected with Grb7 or Grb7D were serum deprived during 18 h and subsequently treated (where indicated) with 10 mM mMLCK-P or 10 mM mCtrl-P for 30 min at 371C. A control without treatment (None) was also included. The Triton X-100-soluble membrane fraction (MF) was probed with an anti-Grb7 antibody (top panels) as described in Materials and methods. Protein stained with Fast Green as loading controls are also shown (bottom panels). The arrow points to the 59 kDa Grb7 or E57.5 kDa Grb7D bands in the top panels, and to the region of migration of these proteins in the bottom panels. (b) HEK293T cells were treated (where indicated) with 1 mM aMLCK-P or 1 mM aCtrl-P for 30 min at 371C. A control without treatment (None) was also included. The Triton X-100-soluble MF and the CF were probed with anti-Grb7 (top panels), and anti-CaM (center panels) antibodies as described in Materials and methods. Protein stained with Fast Green as loading controls are also shown (bottom panels). The arrow points to the 59 kDa Grb7 band (top panels), the 21 kDa CaM band as processed in the presence of EGTA (center panels), and the region of migration of Grb7 (bottom panels)
We used Grb7 transfectants and tumor cells coexpressing Grb7 and ErbB2, a tyrosine kinase receptor partner able to be activated by HRGb1, to search for clues on the action of CaM on the functionality of Grb7 in living cells. In these systems, we tested the effect of W7 and cell-permeable CaM inhibitor peptides.
Tyrosine phosphorylation of recombinant Grb7, Grb7V, and respective deletion mutants could be considered a reasonable indication of the functionality of these foreigner proteins in the host cell, as Grb7 has been known to be phosphorylated by different tyrosine kinases including, the Ret receptor (Pandey et al., 1996) , the EGFR (Tanaka et al., 1998) , FAK (Han and Guan, 1999; Han et al., 2001) , and the EphB1 receptor .
The granular subcellular structure(s) where Grb7D and Grb7VD are concentrated are not yet known, although intracellular vesicles are obvious candidates. We also observed in COS-7 cells transfected with wildtype Grb7 the formation of some intracellular aggregates upon treatment with W7 and EGF (not shown). We have excluded, however, colocalization of the granular Grb7D (in nonstimulated cells) or wild-type Grb7 (in cells stimulated with HRGb1) in early endosomes. This suggests that the observed mobilization of Grb7 induced by HRGb1 does not necessarily correspond to the internalization of a receptor/Grb7 complex.
As a single amino-acid substitution in the PH domain of Grb7 totally impairs the capacity to bind phosphoinositides , the absence of the CaM-BD in Grb7D and Grb7VD could have a similar effect, and this could explain their inability to bind efficiently to the Triton X-100-SM fraction. Our results show, however, that the capacity of Grb7D to bind phosphoinositides is not totally impaired, particularly with respect to phosphatidyl-3-phosphate, and phosphatidyl-3,5-bisphosphate. Moreover, the observed competitive effect of CaM on the binding of phosphoinositides supports the notion that regulation of Grb7 by CaM and phosphoinositides could be mutually exclusive events of physiological importance.
Our results showing FRET between cotransfected ECFP-CaM and EYFP-Grb7, and the fact that this signal is dramatically reduced in BAPTA-AM-loaded cells demonstrate that Grb7/CaM interaction is a Ca 2 þ -dependent process that occurs essentially at the plasma membrane of living cells. Thus, Grb7 at this location, rather than in the cytosol, is under the control of CaM. Furthermore, when EYFP-Grb7D instead of EYFPGrb7 was cotransfected with ECFP-CaM, FRET efficiency significantly diminished, although it was not totally abolished. This is consistent with the residual (2275%, n ¼ 4) CaM-binding capacity of Grb7D in our in vitro experiments. Although the FRET efficiency measured in our experiments was not too high, 4-16% depending of the total cell surface analysed in different independent experiments (n ¼ 8), these values are highly significant, taking in consideration that endogenous native CaM competes with ECFP-CaM for binding to EYFP-Grb7.
Our results also suggest that activation of ErbB2 and its partner, possibly ErbB3 and/or ErbB4, releases Grb7 from the plasma membrane to undertake downstream signaling functions, perhaps locating itself in a different subcellular fraction. Most significantly, the presence of the cell-permeable CaM inhibitor W7 hinders this Figure 11 Abolition of angiogenic activity of conditioned media from cells transfected with Grb7D and Grb7VD. Phase-contrast microphotographs illustrating the morphology of HBE cells seeded in Matrigelt and exposed to serum-free DMEM (panels a and g). Capillary-like tubes formed by HBE cells when exposed to conditioned media from mock-NT (panel b), , and Grb7V-transfected (panels e and h) HEK293T cells. No angiogenic response was observed in HBE cells when exposed to conditioned media from either Grb7D-transfected (panel d) or Grb7VD-transfected (panel f) HEK293T cells. The magnifications were Â 40 (panels a-f) and Â 200 (panels g and h)
process, while the CaMK-II inhibitor KN93 does not, suggesting that CaM directly controls this event. We avoided interfering effects of CaM inhibition on the activity of ErbB2, that is as well under the control of CaM (Li et al., 2004b) , using cell-permeable CaM inhibitory peptides (To¨ro¨k and Trentham, 1994; To¨ro¨k et al., 1998a, b; Thorogate and To¨ro¨k, 2004) in cells not stimulated with HRGb1. Our results show that these peptides are more potent and selective than W7 in preventing the binding of Grb7 to membranes. This demonstrates that CaM directly controls the location of Grb7 at the cell membrane, and that perhaps a different set of proteins are operative in HRGb1-and CaM inhibitor-mediated Grb7 mobilization.
The absence of angiogenic activity of conditioned media from HEK293T cells transfected with Grb7D and Grb7VD as compared to their wild-type counterparts or mock-NT cells further supports the physiological significance of the CaM-BD of these adaptor proteins. Although the mechanism by which the deletion of the CaM-BD affects the angiogenic response of HBE cells to the conditioned media is still unknown, the possibility that it reduces the secretion of proangiogenic factor(s) and/or increases the secretion of antiangiogenic factor(s) by HEK293T cells should be considered. As Grb7D (or Grb7) is not secreted to the extracellular medium (not shown), the mutant protein could be acting as a dominant negative disrupting the homeostasis of proangiogenic and/or antiangiogenic factors secreted by the cell. Although Grb7 was not detected in NT HEK293T cells either by Western blot (see results) or reverse transcriptase-polymerase chain reaction (PCR) (not shown), one possibility is that Grb7D and Grb7VD could compete with a different but related endogenous adaptor protein relevant in the signaling pathway(s) for the production of proangiogenic and/or the repression of antiangiogenic factors.
Grb7 has been implicated in cell migration (Han and Guan, 1999; Han et al., 2001 Han et al., , 2002 , a process that is as well regulated by CaM because of its action on cytoskeleton-associated proteins and/or essential regulatory systems (Means et al., 1982; Goldenring et al., 1986) . Nevertheless, in light of our results, Grb7-mediated cell motility could also be modulated by the Ca 2 þ /CaM-dependent interaction described in this report. We suggest that possible alterations of the Grb7/CaM system in tumor cells could be relevant to understand the high motility observed in many cancerous cells, their metastatic spread, and the development of the neovascularization required for tumor progression. The Grb7/CaM interaction described in this report could conceivably be a new target for therapeutic intervention in order to curtail the invasive potential of malignant cells and/or their associated angiogenesis.
Materials and methods
Reagents
Reagents were obtained as follows: polyclonal human anti-Nterminal and anti-C-terminal Grb7 antibodies, anti-ErbB2/ Neu (C-18) polyclonal antibody, anti-rabbit and anti-mouse IgGs conjugated to FITC secondary antibodies, and UltraCruzt mounting medium from Santa Cruz Biotechnology. Anti-rabbit IgG conjugated to horseradish peroxidase from Zymed Laboratories. Anti-P-Tyr (4G10) 
Cell cultures
Human breast adenocarcinoma SK-BR-3 cells, human embryonic kidney HEK293T cells, COS-7 cells and porcine aorta endothelial cells stably transfected with a human EGFR-GFP chimera (PAE/EGFR-GFP cells) were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% (v/v) fetal bovine serum (FBS), 2 mM L-glutamine, and 40 mg/ ml gentamicin in air enriched with 5% (v/v) CO 2 at 371C. Cells were maintained overnight in FBS-free medium before performing the experiments. HBE cells were obtained from small intracortical microvessels and capillary fractions (20-112 mm) harvested from human temporal cortex excised surgically from patients treated for idiopathic epilepsy. Tissues were obtained with approval from the Institutional Research Ethics Committee. HBE cells were separated from smooth muscle cells with cloning rings and grown as described previously (Stanimirovic et al., 1996) .
Purification of recombinant CaM and preparation of biotinylated CaM
Recombinant rat CaM was purified from E. coli as described (Hayashi et al., 1998) , except that the soluble bacterial CE was heated at 951C for 5 min before the heat-resistant proteins were subjected to phenyl-Sepharose chromatography. Purified CaM was biotinylated using EZ-linkt NHS-LC-biotin as described (Billingsley et al., 1985) .
Plasmid constructs, preparation of recombinant Grb7 and Grb7V deletion mutants, and chimera proteins The Grb7 and Grb7V open reading frames were amplified by PCR using the plasmids pCR3-Flag-Grb7 and pCR3-FlagGrb7V as templates and the following oligonucleotides: for Grb7 forward primer 5 0 -GAT GAC GAT CAT ATG GAG CCG GAT CTG TCT CCA CCT CAT C-3 0 , and reverse primer 5 0 -GCC AGT CCA CGC TCG AGT CAG AGG GCC ACC CGC GTG CAG C-3 0 containing, respectively, NdeI and XhoI restriction sites (underlined); and for Grb7V forward primer 5 0 -GAT GAC GAT CAT ATG GAG CCG GAT CTG TCT CCA CCT CAT C-3 0 , and reverse primer 5 0 -GCA GGA TGA GAT CTC GAG TCA CTT TCT GCA GGT GGC ACA AAG-3 0 containing, respectively, NdeI and XhoI restricGrb7 binds calmodulin H Li et al tion sites (underlined). The PCR products were subcloned into the bacterial expression vector pET-14b to obtain pET-Grb7 and pET-Grb7V. To obtain deletion mutants lacking the CaM-BD (residues 243-256), denoted Grb7D and Grb7VD, the vectors pET-Grb7, pET-Grb7V, pCR3-Flag-Grb7, and pCR3-Flag-Grb7V were used as template for reactions using the ExSite mutagenesis kit and the following oligonucleotides: 5 0 -TCC TGA ACC CCG CAG CTG CAG AAA GCC CTG-3 0 and 5 0 -GGC GTC TAT TAC TCC ACC AAG GGC ACC TCT AAG-3 0 . The correctness of the deletions was determined by automatic sequencing. E. coli strain BL21(DE3)pLysS was transformed with pET-Grb7, pET-Grb7V, pET-Grb7D, and pET-Grb7VD to express the corresponding recombinant proteins upon induction with 1 mM isopropyl-b-D-thiogalactopyranoside (IPTG) for 3 h. The pEYFP-Grb7 and pEYFPGrb7D vectors were prepared using the vector pEYFP-C1 and the open reading frames of Grb7 and Grb7D derived, respectively, from pCR3-Flag-Grb7 and pCR3-Flag-Grb7D eliminating the Flag tag.
Subcellular fractionation
Cells grown to confluence were washed three times with 130 mM NaCl, 2.7 mM KCl, and 11.5 mM sodium/potassium phosphate (pH 7.4) (phosphate-buffered saline, PBS), and harvested in 50 mM N-2-hydroxyethylpiperazine-N 0 -2-ethanesulfonic acid (HEPES)-NaOH (pH 7.4), 150 mM NaCl, 10 mM ethylenediaminetetraacetic acid (EDTA), 50 mM vanadate, and 1 mM PMSF (buffer A). Cells were broken by four swift forced passages through a 25 G 5/8 needle, and centrifuged at 600 g max for 5 min to discard unbroken cells, nucleus, and large debris. The supernatant was centrifuged thereafter at 264 000 g max for 1 h at 41C. The new supernatant (CF) was separated, and the pellet was solubilized in buffer A containing 1% (w/v) Triton X-100 for 45 min on ice. The sample was centrifuged again as indicated above and the resulting supernatant (Triton X-100-SM fraction) was separated from the pellet (Triton X-100-IP fraction). Samples were stored at À201C until used.
Transient cell transfection
HEK293T cells grown in DMEM plus 10% (v/v) FBS to approximately 80% confluence, were treated with 25 mM chloroquine for 20 min, and a 1 ml transfection cocktail containing 6-10 mg vector DNA (pCR3-Flag-Grb7, pCR3-Flag-Grb7V, pCR3-Flag-Grb7D, pCR3-Flag-Grb7VD, pEYFP-Grb7, pEYFP-Grb7D, and/or ECFP-CaM-pcDNA3), 124 mM CaCl 2 , 25 mM HEPES-NaOH (pH 7.05), 5 mM KCl, 125 mM NaCl, 0.75 mM Na 2 HPO 4 , and 6 mM glucose was added immediately dropwise, and then mixed by gentle swirling. The medium was changed at 8-10 h and 24 h later to DMEM plus 10% (v/v) FBS.
Western blot analysis
Immunoblots were performed as described previously (Li et al., 2004b) using anti-N-Grb7 (1/1000 dilution), anti-CGrb7 (1/1000 dilution), anti-Flag (1/5000 dilution), anti-ErbB2 (1/1000 dilution), or anti-P-Tyr (1/4000 dilution) antibodies, and appropriate secondary antibodies coupled to horseradish peroxidase (1/4000 dilution). Loading controls of the electrophoretic tracks was ascertained by protein staining with Fast Green FCF or Ponceau Red S. The positive bands were detected using the enhanced chemiluminescence Luminol (ECLt) method following the instructions from the manufacturer.
CaM-affinity chromatography
Cells were washed twice with ice-cold PBS, removed from the culture dishes and sonicated on ice using 15 burst of 15 s each spaced by 10 s off periods in 20 mM HEPES-NaOH (pH 7.5), 150 mM NaCl, 1 mM EGTA, 1 mM PMSF, 10 mg/ml leupeptin, 10 mg/ml pepstatin A, and 10 mg/ml aprotinin. Bacterial cell extracts were prepared by sonication as above, and centrifuged at 100 000 g max for 1 h. The supernatant was passed through a 3 ml bed volume CaM-agarose column equilibrated with 25 mM HEPES-NaOH (pH 7.5), 135 mM NaCl, and 0.2 mM CaCl 2 (Ca-buffer), and extensively washed (100 ml) with the same buffer. Fractions (1 ml) were collected after elution with the same buffer but with 2 mM EGTA instead of CaCl 2 . Proteins in 3 ml pooled fractions were precipitated with 10% (w/v) trichloroacetic acid and processed for Western blot.
CaM overlay experiments
Whole-cell extracts, bacterial cell extracts, and fractions pulled down by CaM-agarose beads washed three times with a Ca buffer were processed for overlay with 14.5 nM biotinylated CaM in the presence of 0.2 mM CaCl 2 as described previously (Li and Villalobo, 2002) . Controls containing 1 mM EGTA instead of CaCl 2 were performed. The bands were developed using the ECLt method as above. When required, the PVDF membranes were processed for immunoblot after stripping with a medium containing 62.5 mM Tris-HCl (pH 6.7), 100 mM b-mercaptoethanol, and 2% (w/v) sodium dodecyl sulfate at 501C for 30 min or overnight incubation at room temperature.
Cell immunostaining and confocal microscopy
Cells grown on glass coverslips were washed with PBS and fixed with 4% paraformaldehyde for 5 min, permeabilized with 0.5%. (w/v) Triton X-100 in 100 mM NaCl, 0.3 M sucrose, 10 mM piperazine-N,N 0 -bis(ethanesulfonic acid) (Pipes)-NaOH (pH 6.8), and 3 mM MgCl 2 , rinsed with 70% (v/v) ethanol, and rehydrated with PBS. Samples were blocked with 1% (w/v) bovine serum albumin in PBS for 30 min, and probed with anti-Flag (1/500 dilution) and anti-EEA1 (1/200 dilution) antibodies at room temperature for 1 h, and FITC-labeled (1/250 dilution) and Alexa Fluor s 594-labeled (1/750 dilution) secondary antibodies to visualize, respectively, the transfected Flag-tagged Grb7 and Grb7D (green) , and the endosomal protein EEA1 (red). The fluorescence of cells expressing the chimera EGFR-GFP (green) was also determined. The nucleus was visualized upon staining with DAPI (not shown). A Leica TCS SP2 confocal microscope was used to acquire the images after mounting the inverted coverslip. A Â 100 oil-immersion objective was employed, recording images in the x, y, z-mode using the 488 nm argon and the 543 nm argon/helium/neon lasers, and focusing the planes at 1 mm intervals from the bottom to the top to obtain the stacks. The images were acquired and processed using the Leica Microsystems computer software.
FRET experiments
HEK293T cells cotransfected with ECFP-CaM and EYFP-Grb7 (or EYFP-Grb7D), as described above, were used to perform FRET experiments. The FRET efficiency was calculated in selected areas by the acceptor photobleaching technique (Lippincott-Schwartz et al., 2001) using the Leica TCS SP2 confocal microscope software following the equation:
where D pre and D post represent, respectively, the fluorescence emitted by the donor (ECFP-CaM) at 495 nm upon excitation at 458 nm before and after photobleaching of the acceptor (EYFP-Grb7) using the 514 nm laser at 100% potency. Falsecolor images where the FRET efficiency plotted from nil (blue) to high (red) values were generated. The Ca 2 þ dependency of the ECFP-CaM/EYFP-Grb7 interaction was determined in cells incubated with 10 mM BAPTA-AM for 30 min.
Phosphoinositide binding assays
The capacity of Grb7 and Grb7D to bind immobilized phosphoinositides was determined using the PIP Stripst system following the protocol provided by the manufacturer, except that 1 mM EGTA, 100 mM CaCl 2 , and/or 78 mg/ml CaM were added as described in the legend of the figures. CFs (150-200 ml) prepared, as described above, from transiently transfected HEK293T cells with Grb7 and Grb7D, and from mock-NT cells were used. The strips were developed using an antiGrb7 antibody and the ECLt method as described above.
Capillary-like tubes formation
In vitro angiogenesis was assessed by endothelial tubes formation in HBE cells using Matrigelt. In all, 24-well plates were coated with 300 ml of Matrigelt (5-7 mg protein/ml) and allowed to polymerize for 30 min at 371C. A total of 40 000 HBE cells were suspended in 500 ml of DMEM or serum-free conditioned media from either mock, Grb7-, Grb7V-, Grb7D-, and Grb7VD-transfected HEK293T cells, and plated into Matrigelt-coated wells. The serum-free conditioned media were collected after 49 h of cell contact (72 h post-transfection), and passed through a 0.2 mm filter. Capillary-like tubes formation was analysed after 24 h using an Olympus 1 Â 50 microscope equipped with a digital video camera. The experiments were repeated three times in duplicated wells.
Other analytical procedures
Slab gel electrophoreses were performed as described (Laemmli, 1970 ) in a linear gradient 5-20% (w/v) or 10% (w/v) continuous polyacrylamide gels in the presence of 0.1% (w/v) sodium dodecyl sulfate at pH 8.3. Protein concentration was determined using bicinchoninic acid and copper sulfate (BCA method) as described (Stoscheck, 1990) , and bovine serum albumin as standard. The intensity of the bands present in the X-ray films after ECLt development were quantified by a computer-assisted scanner using the NIH Image 1.59 program. Statistical analysis was performed using the Student's t-test for unpaired experiments, considering significant differences Pp0.05.
Abbreviations aCtrl-P, acylated control peptide; aMLCK-P, acylated myosin light-chain kinase peptide; BAPTA-AM, [1,2-bis(o-aminophenoxy)ethane-N,N,N 0 ,N 0 -tetraacetic acid tetra(acetoxymethyl) ester]; B-CaM, biotinylated calmodulin; CaM, calmodulin; CaM-BD, CaM-binding domain; CaMK-II, CaM-dependent protein kinase II; DAPI, 4 0 ,6-diamidino-2-phenylindole; DMEM, Dulbecco's modified Eagle's medium; ECFP-CaM, enhanced cyan fluorescent protein-calmodulin chimera; EYFP-Grb7, enhanced yellow fluorescent protein-Grb7 chimera; EGF, epidermal growth factor; EGFR, EGF receptor; EGFR-GFP, EGFR-green fluorescent protein chimera; EDTA, ethylenediaminetetraacetic acid; EGTA, [ethylene bis(oxyethylenenitrilo)]-tetraacetic acid; FAK, focal adhesion kinase; FBS, fetal bovine serum; FITC, fluorescein isothiocyanate; FRET, fluorescence resonance energy transfer; Grb, growth factor receptor bound; HEPES, N-2-hydroxyethylpiperazine-N 0 -2-ethanesulfonic acid; HRGb1, heregulin b1; IPTG, isopropyl-b-D-thiogalactopyranoside; mCtrl-P, myristoylated control peptide; mMLCK-P, myristoylated myosin light-chain kinase peptide; PBS, phosphate-buffered saline; PCR, polymerase chain reaction; PH, pleckstrin homology; Pipes, piperazine-N,N 0 -bis(ethanesulfonic acid); PMSF, phenylmethylsulfonyl fluoride; P-Tyr, phosphotyrosine; PVDF, polyvinylidene fluoride; SH2, Src homology 2; W7, N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide.
